Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2000
06/21/2000EP1009760A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
06/21/2000EP1009754A1 Presenilin-1 gene promoter
06/21/2000EP1009753A1 Hypoxia-regulated genes
06/21/2000EP1009752A1 Novel molecules of the tango-77 related protein family and uses thereof
06/21/2000EP1009725A1 13c,15n,2h labeled proteins for nmr structure determinations and their preparation
06/21/2000EP1009443A1 priA POLYPEPTIDES
06/21/2000EP1009442A1 Improvements in or relating to regulation of t cell activation
06/21/2000EP1009423A1 EPO PRIMARY RESPONSE GENE, EPRG3pt
06/21/2000EP1009422A1 STRUCTURE OF THE ANKYRIN BINDING DOMAIN OF A ALPHA-Na,K-ATPase
06/21/2000EP1009378A1 Use of the rhoeo discolor plant extracts in cosmetics and pharmaceutics, in particular in dermatology
06/21/2000EP1009220A4 Production of hydroxylated fatty acids in genetically modified plants
06/21/2000EP1009220A1 Production of hydroxylated fatty acids in genetically modified plants
06/21/2000EP0809691A4 Submucosa as a growth substrate for cells
06/21/2000EP0205564B2 Method for the production of erythropoietin
06/21/2000DE19858549A1 Mesothelzellen der viszeralen Pleura Mesothelial cells of the pleura visceral
06/21/2000DE19755801A1 Implant with improved tissue integration
06/21/2000CN1257548A Improvement relating to the specificity of gene expression
06/21/2000CN1257545A Type II TGF-beta receptor/immunoglobulin constant region fusion proteins
06/21/2000CN1257542A Regulation of quinolate phosphoribosyl transferase expression
06/21/2000CN1257541A Plant fatty acid epoxygenase genes and uses therefor
06/21/2000CN1053698C Preparation of erythropoietin by cell culture process
06/20/2000US6077994 Nucleotide sequence coding for a polypeptide that plays a role in the apperance of flowers
06/20/2000US6077834 Combining non-viral receptor ligand and cationic lipid ; adding polynucleotide to form molecular mixture; introducing molecular mixture to cell to enhance delivery of polynucleotide to cell
06/20/2000US6077827 Family of peptides known as xenoxins
06/20/2000US6077710 Parthenogenic oocyte activation
06/20/2000US6077707 Long wavelength engineered fluorescent proteins
06/20/2000US6077706 Helicobacter pylori proteins useful for vaccines and diagnostics
06/20/2000US6077700 Amino acid sequence; for study of cell cycle
06/20/2000US6077697 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
06/20/2000US6077692 Amino acid sequence of polypeptide for use as wound healing agents, antiulcer agents, antidiabetic agents; treatment of inflammatory bowel disease, lung damage, gastrointestinal and oral injury, gut toxicity, skin grafts and disorders
06/20/2000US6077687 Flea aminopeptidase nucleic acid molecules and uses thereof
06/20/2000US6077675 Drug screening by contacting compound with recombinant cell which expresses a nucleic acid encoding the receptor and monitoring for binding or modulation of receptor; anticonvulsants; analgesics; cognition enhancers
06/20/2000US6077663 Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/20/2000US6077517 House dust mite allergen, Der p VII, and uses thereof
06/20/2000CA2080924C Endo-1,4-beta-glucanase genes and their use in plants
06/15/2000WO2000034787A1 Cancer detection method and reagents
06/15/2000WO2000034526A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034511A2 Aβ-PEPTIDE SCREENING ASSAY
06/15/2000WO2000034507A1 A method of isolating stem cells
06/15/2000WO2000034505A1 Expression system for factor viii
06/15/2000WO2000034499A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
06/15/2000WO2000034494A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000WO2000034491A2 An improved efficiency agrobacterium-mediated plant transformation method
06/15/2000WO2000034490A1 A method for manufacturing glycoproteins having human-type glycosylation
06/15/2000WO2000034485A2 Beta-1,3-galactosyltransferase homologs
06/15/2000WO2000034484A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains
06/15/2000WO2000034483A2 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000WO2000034481A2 DRUG TARGETS IN $i(CANDIDA ALBICANS)
06/15/2000WO2000034479A1 Genes of resistance against diseases induced by microorganism belonging to magnapothe grisea, plants transformed by the genes and process for producing the same
06/15/2000WO2000034477A2 Neuron-associated proteins
06/15/2000WO2000034475A2 Grnf4, a gdnf-related neurotrophic factor
06/15/2000WO2000034474A2 Growth factor homolog zvegf3
06/15/2000WO2000034467A1 Cancer cell vaccine
06/15/2000WO2000034462A1 Human hybrid host cell for mammalian gene expression
06/15/2000WO2000034460A1 Vectors having terminal repeat sequence of epstein-barr virus
06/15/2000WO2000034458A1 Activated cation channel of the osteoblast as a mechanism of bone anabolism
06/15/2000WO2000034455A2 Methods and systems useful for transferring genes into pancreatic islets ex vivo and into the pancreas in vivo
06/15/2000WO2000034454A2 Microcellular polymers as cell growth media and novel polymers
06/15/2000WO2000034450A1 Cutinase variants
06/15/2000WO2000034449A2 UDP-N- ACETYL GLUCOSAMINE: GALACTOSE-β1, 3-N- ACETYL GALACTOSAMINE- α-R/ N- ACETYL GLUCOSAMINE -β1, 3-N- ACETYL GALACTOSAMINE- α-R (GlcNAc TO GalNAc) β1,6-N- ACETYL GLUCOSAMINYL TRANSFERASE, C2/4GnT
06/15/2000WO2000034447A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b
06/15/2000WO2000034443A2 Megakaryocyte-induced expansion of hematopoietic stem cells
06/15/2000WO2000034442A2 Application of shear flow stress to smooth muscle cells for the production of implantable structures
06/15/2000WO2000034439A1 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
06/15/2000WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
06/15/2000WO2000034330A1 Cark protein and nucleic acid molecules and uses therefor
06/15/2000WO2000034329A2 Differentiation signal
06/15/2000WO2000034320A1 Fluorescent proteins from non-bioluminiscent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034319A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034308A2 Protein transduction system and methods of use thereof
06/15/2000WO2000034303A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR α-INDUCED EXPRESSION OF CELL ADHESION MOLECULES
06/15/2000WO2000034294A2 Tumor necrosis factor receptor homologue-1 ('trh1')
06/15/2000WO2000033870A2 New cancer treatments
06/15/2000WO2000015649A9 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130
06/15/2000WO2000012678A3 Staphylococcus aureus genes and polypeptides
06/15/2000WO2000009693A3 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
06/15/2000WO2000008178A3 Murine dna molecules encoding polypeptides having kinase functions
06/15/2000WO2000006726A3 Delta-related polypeptides
06/15/2000WO2000006701A9 Improvement of cardiac function by mesenchymal stem cell transplantation
06/15/2000WO2000005374A3 Molecules associated with cell proliferation
06/15/2000WO2000005369A3 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
06/15/2000WO2000001846A3 Characterisation of gene function using double stranded rna inhibition
06/15/2000WO2000001821A3 Neurotransmission associated proteins
06/15/2000WO2000000619A3 MATERIALS AND METHODS FOR THE ALTERATION OF ENZYME AND ACETYL CoA LEVELS IN PLANTS
06/15/2000WO1999066051A3 Nek-related and bub1-related protein kinases
06/15/2000WO1999061452A3 acpS
06/15/2000WO1999061052A9 Oral immunization with papillomavirus virus-like particles
06/15/2000WO1999055858A3 Human nucleic acid sequences obtained from pancreas tumor tissue
06/15/2000WO1999047669A3 Human nucleic acid sequences from tissue of breast tumors
06/15/2000WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/15/2000CA2791961A1 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
06/15/2000CA2746535A1 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000CA2678259A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000CA2354702A1 Cancer detection method and reagents
06/15/2000CA2354612A1 Tumor necrosis factor receptor homologue-1 ("trh1")
06/15/2000CA2354232A1 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000CA2354188A1 Cancer cell vaccine
06/15/2000CA2354073A1 Activated cation channel of the osteoblast as a mechanism of bone anabolism
06/15/2000CA2354044A1 Protein transduction system and methods of use thereof
06/15/2000CA2354026A1 Beta-1,3-galactosyltransferase homologs